The Necessity of Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma Using Antiangiogenic Targeted Therapy After Interferon Alfa-2b

2014 ◽  
Vol 12 (6) ◽  
pp. 447-450 ◽  
Author(s):  
Hasan Mutlu ◽  
Şeyda Gündüz ◽  
Abdullah Büyükçelik ◽  
Özcan Yıldız ◽  
Mükremin Uysal ◽  
...  
Author(s):  
Christopher Weight

This chapter summarizes the findings of a landmark trial of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma performed in the interferon era. All enrolled patients had a good performance status. It found overall survival extended by about 3 months in the cytoreductive-nephrectomy-plus-interferon arm versus the interferon-only arm.


2011 ◽  
Vol 22 (5) ◽  
pp. 1048-1053 ◽  
Author(s):  
S.L. Richey ◽  
S.H. Culp ◽  
E. Jonasch ◽  
P.G. Corn ◽  
L.C. Pagliaro ◽  
...  

2018 ◽  
Vol 199 (4S) ◽  
Author(s):  
Bimal Bhindi ◽  
Elizabeth Habermann ◽  
Ross Mason ◽  
Brian Costello ◽  
Lance Pagliaro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document